Merck & Co, Inc NYSE:MRK recently announced that it is joining forces with The Government of Rwanda, together with QIAGEN NV NASDAQ:QGEN focused to launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.
Rwanda has become the first nation in Africa by offering a comprehensive prevention program that incorporates both HPV vaccination and HPV testing. Rwanda holds a population of 2.72 million women ages 15 years and older.
Merck & Co, Inc NYSE:MRK is basically a Major Drug Manufacturers industry company that holds a portfolio of about 94,000 employees. Company’s stock price is moving slight negatively as on the semi-annual basis Merck & Co, Inc’s share price decreased -8.30% with its relative strength index of 42.
Company’s sales have increased 15.88% during last five consecutive years and resulted $45.99 billion for last consecutive twelve months. The company’s growth of its sales in recent quarter vs. year ago quarter recorded 19.80% which is above the Industry benchmark of 5.80% and above from Standard and Poor’s benchmark of 11.60%.
Merck & Co, Inc NYSE:MRK on April 25, 2011 increased 0.85% and settled to the closing price of $34.33. The overall volume in the last trading session was 9.64 million shares. Its fifty two week range was $30.70-$37.68. The total market capitalization remained $105.84 billion.
Merck & Co, Inc’s current stock price is moving above its 52 week low by 16.80% and moving below from 52 week high price by 7.68%. MRK last month stock price volatility remained 1.16%. In its share capital MRK has 3.09 billion outstanding shares while company’s float is the same 3.05 billion shares. Ownership of company is 74.65% institutional with insiders owning 0.03%.
Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, company works with customers and operate in more than 140 countries to deliver innovative health solutions. Company also demonstrates commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.